{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:13:54Z","timestamp":1773692034917,"version":"3.50.1"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,19]]},"DOI":"10.7759\/cureus.29332","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T15:21:54Z","timestamp":1663600914000},"source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review"],"prefix":"10.7759","author":[{"given":"Zubair Mahmood","family":"Kamal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayeeda","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayukafangha","family":"Etando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emran","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayeda Nazmun","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Farizatul Shima","family":"Wan Ahmad Fakuradzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susmita","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mainul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahnuma","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2017.10.006","article-title":"The emerging neurobiology of bipolar disorder","volume":"41","author":"Harrison PJ","year":"2018","unstructured":"Harrison PJ, Geddes JR, Tunbridge EM. The emerging neurobiology of bipolar disorder. Trends Neurosci. 2018, 41:18-30. 10.1016\/j.tins.2017.10.006","journal-title":"Trends Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125318769235","article-title":"Epidemiology and risk factors for bipolar disorder","volume":"8","author":"Rowland TA","year":"2018","unstructured":"Rowland TA, Marwaha S. Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol. 2018, 8:251-69. 10.1177\/2045125318769235","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1684473","article-title":"Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries","volume":"20","author":"Godman B","year":"2019","unstructured":"Godman B, Grobler C, Van-De-Lisle M, et al.. Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert Opin Pharmacother. 2019, 20:2237-55. 10.1080\/14656566.2019.1684473","journal-title":"Expert Opin Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.05.032","article-title":"Prevalence and correlates of bipolar spectrum disorders in Singapore: Results from the 2016 Singapore Mental Health Study (SMHS 2016)","volume":"274","author":"Teh WL","year":"2020","unstructured":"Teh WL, Abdin E, Vaingankar J, et al.. Prevalence and correlates of bipolar spectrum disorders in Singapore: Results from the 2016 Singapore Mental Health Study (SMHS 2016). J Affect Disord. 2020, 274:339-46. 10.1016\/j.jad.2020.05.032","journal-title":"J Affect Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.05.097","article-title":"Intervention trials for adults with bipolar disorder in low-income and lower-middle-income countries: a systematic review","volume":"311","author":"Arnbjerg CJ","year":"2022","unstructured":"Arnbjerg CJ, Rurangwa NU, Musoni-Rwililiza E, Gishoma D, Carlsson J, Kallestrup P. Intervention trials for adults with bipolar disorder in low-income and lower-middle-income countries: a systematic review. J Affect Disord. 2022, 311:256-66. 10.1016\/j.jad.2022.05.097","journal-title":"J Affect Disord"},{"key":"ref6","article-title":"Bipolar Affective Disorder","author":"Jain A","year":"2022","unstructured":"Jain A, Mitra P. Bipolar Affective Disorder. StatPearls Publishing [Internet], Treasure Island (FL); 2022."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2008.10.2\/maescamilla","article-title":"Genetics of bipolar disorder","volume":"10","author":"Escamilla MA","year":"2008","unstructured":"Escamilla MA, Zavala JM. Genetics of bipolar disorder. Dialogues Clin Neurosci. 2008, 10:141-52. 10.31887\/DCNS.2008.10.2\/maescamilla","journal-title":"Dialogues Clin Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.03.080","article-title":"The genetics of bipolar disorder","volume":"164","author":"Barnett JH","year":"2009","unstructured":"Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience. 2009, 164:331-43. 10.1016\/j.neuroscience.2009.03.080","journal-title":"Neuroscience"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-021-01729-5","article-title":"Health-related quality of life among patients with bipolar disorder in rural southwestern Uganda: a hospital based cross sectional study","volume":"19","author":"Anyayo L","year":"2021","unstructured":"Anyayo L, Ashaba S, Kaggwa MM, Maling S, Nakimuli-Mpungu E. Health-related quality of life among patients with bipolar disorder in rural southwestern Uganda: a hospital based cross sectional study. Health Qual Life Outcomes. 2021, 19:84. 10.1186\/s12955-021-01729-5","journal-title":"Health Qual Life Outcomes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-017-0078-4","article-title":"Poor quality of life and functioning in bipolar disorder","volume":"5","author":"Sylvia LG","year":"2017","unstructured":"Sylvia LG, Montana RE, Deckersbach T, et al.. Poor quality of life and functioning in bipolar disorder. Int J Bipolar Disord. 2017, 5:10. 10.1186\/s40345-017-0078-4","journal-title":"Int J Bipolar Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.12.3.251","article-title":"Psychotherapy for bipolar disorder in adults: a review of the evidence","volume":"12","author":"Swartz HA","year":"2014","unstructured":"Swartz HA, Swanson J. Psychotherapy for bipolar disorder in adults: a review of the evidence. Focus (Am Psychiatr Publ). 2014, 12:251-66. 10.1176\/appi.focus.12.3.251","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2013.0145","article-title":"Dialectical behavior therapy for adolescents with bipolar disorder: results from a pilot randomized trial","volume":"25","author":"Goldstein TR","year":"2015","unstructured":"Goldstein TR, Fersch-Podrat RK, Rivera M, et al.. Dialectical behavior therapy for adolescents with bipolar disorder: results from a pilot randomized trial. J Child Adolesc Psychopharmacol. 2015, 25:140-9. 10.1089\/cap.2013.0145","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2174\/1745017901410010140","article-title":"Psychotherapy of mood disorders","volume":"10","author":"Picardi A","year":"2014","unstructured":"Picardi A, Gaetano P. Psychotherapy of mood disorders. Clin Pract Epidemiol Ment Health. 2014, 10:140-58. 10.2174\/1745017901410010140","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/2194-7511-1-5","article-title":"Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data","volume":"1","author":"Bauer M","year":"2013","unstructured":"Bauer M, Glenn T, Alda M, et al.. Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data. Int J Bipolar Disord. 2013, 1:5. 10.1186\/2194-7511-1-5","journal-title":"Int J Bipolar Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0004867417695889","article-title":"Lithium: a classic drug-frequently discussed, but, sadly, seldom prescribed!","volume":"51","author":"Zivanovic O","year":"2017","unstructured":"Zivanovic O. Lithium: a classic drug-frequently discussed, but, sadly, seldom prescribed!. Aust N Z J Psychiatry. 2017, 51:886-96. 10.1177\/0004867417695889","journal-title":"Aust N Z J Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2011.00260.x","article-title":"Lithium: still a major option in the management of bipolar disorder","volume":"18","author":"Licht RW","year":"2012","unstructured":"Licht RW. Lithium: still a major option in the management of bipolar disorder. CNS Neurosci Ther. 2012, 18:219-26. 10.1111\/j.1755-5949.2011.00260.x","journal-title":"CNS Neurosci Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/bs6030014","article-title":"Historical underpinnings of bipolar disorder diagnostic criteria","volume":"6","author":"Mason BL","year":"2016","unstructured":"Mason BL, Brown ES, Croarkin PE. Historical underpinnings of bipolar disorder diagnostic criteria. Behav Sci (Basel). 2016, 6:10.3390\/bs6030014","journal-title":"Behav Sci (Basel)"},{"key":"ref18","unstructured":"Marlier K. Melancholia and Mania. The Historical Contributions of Aretaeus of Cappadocia and Emil Kraepelin. (2020). Accessed: July 23, 2021: http:\/\/hdl.handle.net\/1880\/111923."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2020.1765517","article-title":"From dysthymia to treatment-resistant depression: evolution of a psychopathological construct","volume":"32","author":"Ventriglio A","year":"2020","unstructured":"Ventriglio A, Bhugra D, Sampogna G, Luciano M, De Berardis D, Sani G, Fiorillo A. From dysthymia to treatment-resistant depression: evolution of a psychopathological construct. Int Rev Psychiatry. 2020, 32:471-6. 10.1080\/09540261.2020.1765517","journal-title":"Int Rev Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0957154X19898653","article-title":"Wild melancholy. On the historical plausibility of a black bile theory of blood madness, or h\u00e6matomania","volume":"31","author":"Verplaetse J","year":"2020","unstructured":"Verplaetse J. Wild melancholy. On the historical plausibility of a black bile theory of blood madness, or h\u00e6matomania. Hist Psychiatry. 2020, 31:131-46. 10.1177\/0957154X19898653","journal-title":"Hist Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(01)00429-3","article-title":"Bipolarity from ancient to modern times: conception, birth and rebirth","volume":"67","author":"Angst J","year":"2001","unstructured":"Angst J, Marneros A. Bipolarity from ancient to modern times: conception, birth and rebirth. J Affect Disord. 2001, 67:3-19. 10.1016\/s0165-0327(01)00429-3","journal-title":"J Affect Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(00)00909-4","article-title":"Historical perspectives and natural history of bipolar disorder","volume":"48","author":"Angst J","year":"2000","unstructured":"Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry. 2000, 48:445-57. 10.1016\/s0006-3223(00)00909-4","journal-title":"Biol Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1590\/1980-57642020dn14-030014","article-title":"Neuropsychiatric symptoms in brain diseases - historical foundations","volume":"14","author":"Engelhardt E","year":"2020","unstructured":"Engelhardt E, Sudo FK, Alves GS, Laks J. Neuropsychiatric symptoms in brain diseases - historical foundations. Dement Neuropsychol. 2020, 14:324-8. 10.1590\/1980-57642020dn14-030014","journal-title":"Dement Neuropsychol"},{"key":"ref24","article-title":"Manic-depressive insanity and paranoia","volume":"56","author":"Kraepelin E","year":"1921","unstructured":"Kraepelin E, . Manic-depressive insanity and paranoia. Ind Med Gaz. 1921, 56:156-7.","journal-title":"Ind Med Gaz"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-54802-5_1","article-title":"Introduction: Disordered Mood as Historical Problem","author":"Jansson \u00c5","year":"2021","unstructured":"Jansson \u00c5. Introduction: Disordered Mood as Historical Problem. From Melancholia to Depression. Mental Health in Historical Perspective. Palgrave Macmillan, Cham; 2021. 10.1007\/978-3-030-54802-5_1"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1159\/000493685","article-title":"Research domain criteria: cutting edge neuroscience or Galen's humors revisited?","volume":"4","author":"Ross CA","year":"2018","unstructured":"Ross CA, Margolis RL. Research domain criteria: cutting edge neuroscience or Galen's humors revisited?. Mol Neuropsychiatry. 2018, 4:158-63. 10.1159\/000493685","journal-title":"Mol Neuropsychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2015.00081","article-title":"Melancholia before the twentieth century: fear and sorrow or partial insanity?","volume":"6","author":"Telles-Correia D","year":"2015","unstructured":"Telles-Correia D, Marques JG. Melancholia before the twentieth century: fear and sorrow or partial insanity?. Front Psychol. 2015, 6:81. 10.3389\/fpsyg.2015.00081","journal-title":"Front Psychol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02115-2","article-title":"From sadness to stiffness: the spleen's progress","volume":"14","author":"Riva MA","year":"2019","unstructured":"Riva MA, Ferraina F, Paleari A, Lenti MV, Di Sabatino A. From sadness to stiffness: the spleen's progress. Intern Emerg Med. 2019, 14:739-43. 10.1007\/s11739-019-02115-2","journal-title":"Intern Emerg Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X1503170228185225","article-title":"Editorial: \"The faces of mania: the legacy of Athanasios Koukopoulos\"","volume":"15","author":"Sani G","year":"2017","unstructured":"Sani G, Kotzalidis GD, Girardi P. Editorial: \"The faces of mania: the legacy of Athanasios Koukopoulos\". Curr Neuropharmacol. 2017, 15:334-7. 10.2174\/1570159X1503170228185225","journal-title":"Curr Neuropharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.400","article-title":"Expressed emotion in a woman with bipolar disorder: a case report from Deli Serdang","volume":"7","author":"Putri IV","year":"2019","unstructured":"Putri IV, Effendy E. Expressed emotion in a woman with bipolar disorder: a case report from Deli Serdang. Open Access Maced J Med Sci. 2019, 7:2671-4. 10.3889\/oamjms.2019.400","journal-title":"Open Access Maced J Med Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5137\/1019-5149.JTN.12347-14.0","article-title":"Aretaeus of Cappadocia and his treatises on diseases","volume":"25","author":"Tekiner H","year":"2015","unstructured":"Tekiner H. Aretaeus of Cappadocia and his treatises on diseases. Turk Neurosurg. 2015, 25:508-12. 10.5137\/1019-5149.JTN.12347-14.0","journal-title":"Turk Neurosurg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19072143","article-title":"A history of the pharmacological treatment of bipolar disorder","volume":"19","author":"L\u00f3pez-Mu\u00f1oz F","year":"2018","unstructured":"L\u00f3pez-Mu\u00f1oz F, Shen WW, D'Ocon P, Romero A, \u00c1lamo C. A history of the pharmacological treatment of bipolar disorder. Int J Mol Sci. 2018, 19:10.3390\/ijms19072143","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.148","article-title":"The genealogy of major depression: symptoms and signs of melancholia from 1880 to 1900","volume":"22","author":"Kendler KS","year":"2017","unstructured":"Kendler KS. The genealogy of major depression: symptoms and signs of melancholia from 1880 to 1900. Mol Psychiatry. 2017, 22:1539-53. 10.1038\/mp.2017.148","journal-title":"Mol Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/s0920-9964(02)00328-6","article-title":"Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia","volume":"57","author":"Angst J","year":"2002","unstructured":"Angst J. Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia. Schizophr Res. 2002, 57:5-13. 10.1016\/s0920-9964(02)00328-6","journal-title":"Schizophr Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.9.1127","article-title":"Falret's discovery: the origin of the concept of bipolar affective illness. Translated by M. J. Sedler and Eric C. Dessain","volume":"140","author":"Sedler MJ","year":"1983","unstructured":"Sedler MJ. Falret's discovery: the origin of the concept of bipolar affective illness. Translated by M. J. Sedler and Eric C. Dessain. Am J Psychiatry. 1983, 140:1127-33. 10.1176\/ajp.140.9.1127","journal-title":"Am J Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.04.005","article-title":"Biphasic course in bipolar II outpatients: prevalence and clinical correlates of a cyclic pattern described by Baillarger and Falret in hospitalised patients in 1854","volume":"96","author":"Benazzi F","year":"2006","unstructured":"Benazzi F, Akiskal HS. Biphasic course in bipolar II outpatients: prevalence and clinical correlates of a cyclic pattern described by Baillarger and Falret in hospitalised patients in 1854. J Affect Disord. 2006, 96:183-7. 10.1016\/j.jad.2004.04.005","journal-title":"J Affect Disord"},{"key":"ref37","article-title":"Circular insanity, 150 years on (Article in French)","volume":"188","author":"Pichot P","year":"2004","unstructured":"Pichot P. Circular insanity, 150 years on (Article in French). Bull Acad Natl Med. 2004, 188:275-84.","journal-title":"Bull Acad Natl Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.09.014","article-title":"French antecedents of \"contemporary\" concepts in the American Psychiatric Association's classification of bipolar (mood) disorders","volume":"96","author":"Haustgen T","year":"2006","unstructured":"Haustgen T, Akiskal H. French antecedents of \"contemporary\" concepts in the American Psychiatric Association's classification of bipolar (mood) disorders. J Affect Disord. 2006, 96:149-63. 10.1016\/j.jad.2006.09.014","journal-title":"J Affect Disord"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.12.200","article-title":"Kraepelin's final views on manic-depressive Illness","volume":"282","author":"Kendler KS","year":"2021","unstructured":"Kendler KS. Kraepelin's final views on manic-depressive Illness. J Affect Disord. 2021, 282:979-90. 10.1016\/j.jad.2020.12.200","journal-title":"J Affect Disord"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-1048-6","article-title":"120th anniversary of the Kraepelinian dichotomy of psychiatric disorders","volume":"21","author":"Rybakowski JK","year":"2019","unstructured":"Rybakowski JK. 120th anniversary of the Kraepelinian dichotomy of psychiatric disorders. Curr Psychiatry Rep. 2019, 21:65. 10.1007\/s11920-019-1048-6","journal-title":"Curr Psychiatry Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.12740\/PP\/132961","article-title":"Etiopathogenesis of bipolar affective disorder - the state of the art for 2021","author":"Rybakowski J","year":"2021","unstructured":"Rybakowski J. Etiopathogenesis of bipolar affective disorder - the state of the art for 2021. Psychiatr Pol. 2021. 55:481-96. 10.12740\/PP\/132961"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/09647040490510470","article-title":"The psychiatric works of Emil Kraepelin: a many-faceted story of modern medicine","volume":"13","author":"Decker HS","year":"2004","unstructured":"Decker HS. The psychiatric works of Emil Kraepelin: a many-faceted story of modern medicine. J Hist Neurosci. 2004, 13:248-76. 10.1080\/09647040490510470","journal-title":"J Hist Neurosci"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1086\/687834","article-title":"Tempering madness: Emil Kraepelin\u2019s research on affective disorders","volume":"31","author":"Engstrom EJ","year":"2016","unstructured":"Engstrom EJ. Tempering madness: Emil Kraepelin\u2019s research on affective disorders. Osiris. 2016, 31:163-80.","journal-title":"Osiris"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.64591","article-title":"Emil Kraepelin: a pioneer of scientific understanding of psychiatry and psychopharmacology","volume":"52","author":"Ebert A","year":"2010","unstructured":"Ebert A, B\u00e4r KJ. Emil Kraepelin: a pioneer of scientific understanding of psychiatry and psychopharmacology. Indian J Psychiatry. 2010, 52:191-2. 10.4103\/0019-5545.64591","journal-title":"Indian J Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00706.x","article-title":"The history of lithium therapy","volume":"11 Suppl 2","author":"Shorter E","year":"2009","unstructured":"Shorter E. The history of lithium therapy. Bipolar Disord. 2009, 11 Suppl 2:4-9. 10.1111\/j.1399-5618.2009.00706.x","journal-title":"Bipolar Disord"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/j.1440-1614.1999.06241.x","article-title":"Lithium salts in the treatment of psychotic excitement","volume":"2","author":"CA JF","year":"1949","unstructured":"CA JF. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949, 2:349-52. 10.1080\/j.1440-1614.1999.06241.x","journal-title":"Med J Aust"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0b013e318275d3cb","article-title":"Cade's identification of lithium for manic-depressive illness--the prospector who found a gold nugget","volume":"200","author":"Cole N","year":"2012","unstructured":"Cole N, Parker G. Cade's identification of lithium for manic-depressive illness--the prospector who found a gold nugget. J Nerv Ment Dis. 2012, 200:1101-4. 10.1097\/NMD.0b013e318275d3cb","journal-title":"J Nerv Ment Dis"},{"key":"ref48","article-title":"Lithium treatment for bipolar disorder","volume":"78","author":"Mitchell PB","year":"2000","unstructured":"Mitchell PB, Hadzi-Pavlovic D. Lithium treatment for bipolar disorder. Bull World Health Organ. 2000, 78:515-7.","journal-title":"Bull World Health Organ"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1967.01730200030005","article-title":"Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis","volume":"16","author":"Baastrup PC","year":"1967","unstructured":"Baastrup PC, Schou M. Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry. 1967, 16:162-72. 10.1001\/archpsyc.1967.01730200030005","journal-title":"Arch Gen Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(70)92870-9","article-title":"Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders","volume":"2","author":"Baastrup PC","year":"1970","unstructured":"Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet. 1970, 2:326-30. 10.1016\/s0140-6736(70)92870-9","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(01)00380-9","article-title":"Lithium treatment at 52","volume":"67","author":"Schou M","year":"2001","unstructured":"Schou M. Lithium treatment at 52. J Affect Disord. 2001, 67:21-32. 10.1016\/s0165-0327(01)00380-9","journal-title":"J Affect Disord"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1614.1999.00667.x","article-title":"The early European lithium studies","volume":"33 Suppl","author":"Schou M","year":"1999","unstructured":"Schou M. The early European lithium studies. Aust N Z J Psychiatry. 1999, 33 Suppl:S39-47. 10.1111\/j.1440-1614.1999.00667.x","journal-title":"Aust N Z J Psychiatry"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-73280-5_13","article-title":"Lithium in manic-depressive illness: plusses, pitfalls, and perspectives","volume":"5","author":"Schou M","year":"1988","unstructured":"Schou M. Lithium in manic-depressive illness: plusses, pitfalls, and perspectives. Psychopharmacol Ser. 1988, 5:140-6. 10.1007\/978-3-642-73280-5_13","journal-title":"Psychopharmacol Ser"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1159\/000284961","article-title":"Prophylactic lithium treatment of unipolar and bipolar manic-depressive illness","volume":"28 Suppl 1","author":"Schou M","year":"1995","unstructured":"Schou M. Prophylactic lithium treatment of unipolar and bipolar manic-depressive illness. Psychopathology. 1995, 28 Suppl 1:81-5. 10.1159\/000284961","journal-title":"Psychopathology"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.196974","article-title":"Clinical practice guidelines for management of bipolar disorder","volume":"59","author":"Shah N","year":"2017","unstructured":"Shah N, Grover S, Rao GP. Clinical practice guidelines for management of bipolar disorder. Indian J Psychiatry. 2017, 59:S51-66. 10.4103\/0019-5545.196974","journal-title":"Indian J Psychiatry"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-006-0055-6","article-title":"Pharmacotherapy of bipolar depression: an update","volume":"8","author":"Thase ME","year":"2006","unstructured":"Thase ME. Pharmacotherapy of bipolar depression: an update. Curr Psychiatry Rep. 2006, 8:478-88. 10.1007\/s11920-006-0055-6","journal-title":"Curr Psychiatry Rep"},{"key":"ref57","article-title":"Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments","volume":"7","author":"Jann MW","year":"2014","unstructured":"Jann MW. Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments. Am Health Drug Benefits. 2014, 7:489-99.","journal-title":"Am Health Drug Benefits"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0073-y","article-title":"Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis","volume":"27","author":"Vieta E","year":"2013","unstructured":"Vieta E, Valent\u00ed M. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis. CNS Drugs. 2013, 27:515-29. 10.1007\/s40263-013-0073-y","journal-title":"CNS Drugs"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-018-0133-9","article-title":"Antidepressants in bipolar depression: an enduring controversy","volume":"6","author":"Gitlin MJ","year":"2018","unstructured":"Gitlin MJ. Antidepressants in bipolar depression: an enduring controversy. Int J Bipolar Disord. 2018, 6:25. 10.1186\/s40345-018-0133-9","journal-title":"Int J Bipolar Disord"},{"key":"ref60","article-title":"Treatment for Bipolar Disorder in Adults: A Systematic Review [Internet]","author":"Butler M","year":"2018","unstructured":"Butler M, Urosevic S, Desai P, et al.. Treatment for Bipolar Disorder in Adults: A Systematic Review [Internet]. 2018 (ed): Agency for Healthcare Research and Quality (US), Rockville (MD); 2018."},{"key":"ref61","unstructured":"Treatment - Bipolar disorder. (2022). Accessed. July 26, 2022: https:\/\/www.nhs.uk\/mental-health\/conditions\/bipolar-disorder\/treatment\/ ."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00714.x","article-title":"The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis","volume":"11 Suppl 2","author":"Machado-Vieira R","year":"2009","unstructured":"Machado-Vieira R, Manji HK, Zarate CA Jr. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009, 11 Suppl 2:92-109. 10.1111\/j.1399-5618.2009.00714.x","journal-title":"Bipolar Disord"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-019-0151-2","article-title":"Clinical use of lithium salts: guide for users and prescribers","volume":"7","author":"Tondo L","year":"2019","unstructured":"Tondo L, Alda M, Bauer M, et al.. Clinical use of lithium salts: guide for users and prescribers. Int J Bipolar Disord. 2019, 7:16. 10.1186\/s40345-019-0151-2","journal-title":"Int J Bipolar Disord"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00377","article-title":"Lithium treatment over the lifespan in bipolar disorders","volume":"11","author":"Volkmann C","year":"2020","unstructured":"Volkmann C, Bschor T, K\u00f6hler S. Lithium treatment over the lifespan in bipolar disorders. Front Psychiatry. 2020, 11:377. 10.3389\/fpsyt.2020.00377","journal-title":"Front Psychiatry"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312471963","article-title":"Lithium: the pharmacodynamic actions of the amazing ion","volume":"3","author":"Brown KM","year":"2013","unstructured":"Brown KM, Tracy DK. Lithium: the pharmacodynamic actions of the amazing ion. Ther Adv Psychopharmacol. 2013, 3:163-76. 10.1177\/2045125312471963","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0039-0","article-title":"Potential mechanisms of action of lithium in bipolar disorder. Current understanding","volume":"27","author":"Malhi GS","year":"2013","unstructured":"Malhi GS, Tanious M, Das P, Coulston CM, Berk M. Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs. 2013, 27:135-53. 10.1007\/s40263-013-0039-0","journal-title":"CNS Drugs"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083908","article-title":"Lithium enhances the GABAergic synaptic activities on the hypothalamic preoptic area (hPOA) neurons","volume":"22","author":"Rijal S","year":"2021","unstructured":"Rijal S, Jang SH, Park SJ, Han SK. Lithium enhances the GABAergic synaptic activities on the hypothalamic preoptic area (hPOA) neurons. Int J Mol Sci. 2021, 22:3908. 10.3390\/ijms22083908","journal-title":"Int J Mol Sci"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12074","article-title":"Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder","volume":"15","author":"Brady RO Jr","year":"2013","unstructured":"Brady RO Jr, McCarthy JM, Prescot AP, et al.. Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder. Bipolar Disord. 2013, 15:434-9. 10.1111\/bdi.12074","journal-title":"Bipolar Disord"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300920","article-title":"Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats","volume":"31","author":"Basselin M","year":"2006","unstructured":"Basselin M, Chang L, Bell JM, Rapoport SI. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology. 2006, 31:1659-74. 10.1038\/sj.npp.1300920","journal-title":"Neuropsychopharmacology"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00929-X","article-title":"Signaling: cellular insights into the pathophysiology of bipolar disorder","volume":"48","author":"Manji HK","year":"2000","unstructured":"Manji HK, Lenox RH. Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry. 2000, 48:518-30. 10.1016\/S0006-3223(00)00929-X","journal-title":"Biol Psychiatry"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2014.02.004","article-title":"Molecular actions and clinical pharmacogenetics of lithium therapy","volume":"123","author":"Can A","year":"2014","unstructured":"Can A, Schulze TG, Gould TD. Molecular actions and clinical pharmacogenetics of lithium therapy. Pharmacol Biochem Behav. 2014, 123:3-16. 10.1016\/j.pbb.2014.02.004","journal-title":"Pharmacol Biochem Behav"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.2174\/1567205013666160219112712","article-title":"Neuroprotective effects of lithium in human brain? Food for thought","volume":"13","author":"Hajek T","year":"2016","unstructured":"Hajek T, Weiner MW. Neuroprotective effects of lithium in human brain? Food for thought. Curr Alzheimer Res. 2016, 13:862-72. 10.2174\/1567205013666160219112712","journal-title":"Curr Alzheimer Res"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1021\/cn5000309","article-title":"Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders","volume":"5","author":"Forlenza OV","year":"2014","unstructured":"Forlenza OV, De-Paula VJ, Diniz BS. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014, 5:443-50. 10.1021\/cn5000309","journal-title":"ACS Chem Neurosci"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-45138","article-title":"Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders","volume":"36 Suppl 3","author":"Bauer M","year":"2003","unstructured":"Bauer M, Alda M, Priller J, Young LT. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry. 2003, 36 Suppl 3:S250-4. 10.1055\/s-2003-45138","journal-title":"Pharmacopsychiatry"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3727\/096368909X471251","article-title":"Review of lithium effects on brain and blood","volume":"18","author":"Young W","year":"2009","unstructured":"Young W. Review of lithium effects on brain and blood. Cell Transplant. 2009, 18:951-75. 10.3727\/096368909X471251","journal-title":"Cell Transplant"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2007.05.018","article-title":"Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord","volume":"206","author":"Su H","year":"2007","unstructured":"Su H, Chu TH, Wu W. Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp Neurol. 2007, 206:296-307. 10.1016\/j.expneurol.2007.05.018","journal-title":"Exp Neurol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.05902.x","article-title":"Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor","volume":"108","author":"Su H","year":"2009","unstructured":"Su H, Zhang W, Guo J, Guo A, Yuan Q, Wu W. Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor. J Neurochem. 2009, 108:1385-98. 10.1111\/j.1471-4159.2009.05902.x","journal-title":"J Neurochem"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2016.02.006","article-title":"Lithium and suicide prevention in bipolar disorder","volume":"42","author":"Benard V","year":"2016","unstructured":"Benard V, Vaiva G, Masson M, Geoffroy PA. Lithium and suicide prevention in bipolar disorder. Encephale. 2016, 42:234-41. 10.1016\/j.encep.2016.02.006","journal-title":"Encephale"},{"key":"ref79","article-title":"Lithium suicide prevention: a brief review and reminder","volume":"15","author":"Sarai SK","year":"2018","unstructured":"Sarai SK, Mekala HM, Lippmann S. Lithium suicide prevention: a brief review and reminder. Innov Clin Neurosci. 2018, 15:30-2.","journal-title":"Innov Clin Neurosci"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin M","year":"2016","unstructured":"Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016, 4:27. 10.1186\/s40345-016-0068-y","journal-title":"Int J Bipolar Disord"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.05.2011.4267","article-title":"Strange taste and mild lithium intoxication","volume":"2011","author":"Terao T","year":"2011","unstructured":"Terao T, Watanabe S, Hoaki N, Hoaki T. Strange taste and mild lithium intoxication. BMJ Case Rep. 2011, 2011:10.1136\/bcr.05.2011.4267","journal-title":"BMJ Case Rep"},{"key":"ref82","article-title":"Lithium Toxicity","author":"Hedya SA","year":"2022","unstructured":"Hedya SA, Avula A, Swoboda HD. Lithium Toxicity. StatPearls Publishing [Internet], Treasure Island (FL); 2022."},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2010.71.4.47513","article-title":"Lithium toxicity: the importance of clinical signs","volume":"71","author":"Dunne FJ","year":"2010","unstructured":"Dunne FJ. Lithium toxicity: the importance of clinical signs. Br J Hosp Med (Lond). 2010, 71:206-10. 10.12968\/hmed.2010.71.4.47513","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5369297","article-title":"A case report on an atypical presentation of the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT) in a war veteran with bipolar disorder and PTSD","volume":"2020","author":"Se\u00f1ga MM","year":"2020","unstructured":"Se\u00f1ga MM, Sarapuddin G, Saniel E. A case report on an atypical presentation of the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT) in a war veteran with bipolar disorder and PTSD. Case Rep Psychiatry. 2020, 2020:5369297. 10.1155\/2020\/5369297","journal-title":"Case Rep Psychiatry"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7176.135399","article-title":"Serum lithium levels: ideal time for sample collection! are we doing it right?","volume":"36","author":"Reddy DS","year":"2014","unstructured":"Reddy DS, Reddy MS. Serum lithium levels: ideal time for sample collection! are we doing it right?. Indian J Psychol Med. 2014, 36:346-7. 10.4103\/0253-7176.135399","journal-title":"Indian J Psychol Med"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00475.x","article-title":"What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?","volume":"10","author":"Severus WE","year":"2008","unstructured":"Severus WE, Kleindienst N, Seem\u00fcller F, Frangou S, M\u00f6ller HJ, Greil W. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?. Bipolar Disord. 2008, 10:231-7. 10.1111\/j.1399-5618.2007.00475.x","journal-title":"Bipolar Disord"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12805","article-title":"What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD\/IGSLI Task Force on treatment with lithium","volume":"21","author":"Nolen WA","year":"2019","unstructured":"Nolen WA, Licht RW, Young AH, et al.. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD\/IGSLI Task Force on treatment with lithium. Bipolar Disord. 2019, 21:394-409. 10.1111\/bdi.12805","journal-title":"Bipolar Disord"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12623","article-title":"Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies","author":"Kessing LV","year":"2018","unstructured":"Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord. 2018, 10.1111\/bdi.12623","journal-title":"Bipolar Disord"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1080\/j.1440-1614.2005.01649.x","article-title":"Maintenance therapies in bipolar disorder: focus on randomized controlled trials","volume":"39","author":"Muzina DJ","year":"2005","unstructured":"Muzina DJ, Calabrese JR. Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Aust N Z J Psychiatry. 2005, 39:652-61. 10.1080\/j.1440-1614.2005.01649.x","journal-title":"Aust N Z J Psychiatry"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145703003535","article-title":"Acute and maintenance treatment with mood stabilizers","volume":"6","author":"Bowden CL","year":"2003","unstructured":"Bowden CL. Acute and maintenance treatment with mood stabilizers. Int J Neuropsychopharmacol. 2003, 6:269-75. 10.1017\/S1461145703003535","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1177\/00048674221077619","article-title":"Lithium plus antipsychotics or anticonvulsants for bipolar disorder: comparing clinical response and metabolic changes","author":"K\u00f6hler-Forsberg O","year":"2022","unstructured":"K\u00f6hler-Forsberg O, Sylvia LG, Thase M, et al.. Lithium plus antipsychotics or anticonvulsants for bipolar disorder: comparing clinical response and metabolic changes. Aust N Z J Psychiatry. 2022, 48674221077619. 10.1177\/00048674221077619","journal-title":"Aust N Z J Psychiatry"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2011.00234.x","article-title":"Treatment strategies for dosing the second generation antipsychotics","volume":"17","author":"Schwartz TL","year":"2011","unstructured":"Schwartz TL, Stahl SM. Treatment strategies for dosing the second generation antipsychotics. CNS Neurosci Ther. 2011, 17:110-7. 10.1111\/j.1755-5949.2011.00234.x","journal-title":"CNS Neurosci Ther"},{"key":"ref93","article-title":"Antipsychotic Medications","author":"Chokhawala K","year":"2022","unstructured":"Chokhawala K, Stevens L. Antipsychotic Medications. StatPearls Publishing [Internet], Treasure Island (FL); 2022."},{"key":"ref94","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri MC","year":"2014","unstructured":"Mauri MC, Paletta S, Maffini M, Colasanti A, Dragogna F, Di Pace C, Altamura AC. Clinical pharmacology of atypical antipsychotics: an update. EXCLI J. 2014, 13:1163-91.","journal-title":"EXCLI J"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S50961","article-title":"Lurasidone for the treatment of bipolar depression: an evidence-based review","volume":"11","author":"Franklin R","year":"2015","unstructured":"Franklin R, Zorowitz S, Corse AK, Widge AS, Deckersbach T. Lurasidone for the treatment of bipolar depression: an evidence-based review. Neuropsychiatr Dis Treat. 2015, 11:2143-52. 10.2147\/NDT.S50961","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2015.13.1.25","article-title":"Pharmacotherapy of bipolar disorder with quetiapine: a recent literature review and an update","volume":"13","author":"Muneer A","year":"2015","unstructured":"Muneer A. Pharmacotherapy of bipolar disorder with quetiapine: a recent literature review and an update. Clin Psychopharmacol Neurosci. 2015, 13:25-35. 10.9758\/cpn.2015.13.1.25","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-101","article-title":"Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials","volume":"11","author":"Szegedi A","year":"2011","unstructured":"Szegedi A, Zhao J, van Willigenburg A, Nations KR, Mackle M, Panagides J. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials. BMC Psychiatry. 2011, 11:101. 10.1186\/1471-244X-11-101","journal-title":"BMC Psychiatry"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316674698","article-title":"Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study","volume":"7","author":"De Filippis S","year":"2017","unstructured":"De Filippis S, Cuomo I, Kotzalidis GD, et al.. Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study. Ther Adv Psychopharmacol. 2017, 7:67-77. 10.1177\/2045125316674698","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup TS","year":"2018","unstructured":"Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018, 17:341-56. 10.1002\/wps.20567","journal-title":"World Psychiatry"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319836566","article-title":"Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders","volume":"9","author":"Wunderink L","year":"2019","unstructured":"Wunderink L. Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders. Ther Adv Psychopharmacol. 2019, 9:2045125319836566. 10.1177\/2045125319836566","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.6.559","article-title":"Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder","volume":"187","author":"Chisholm D","year":"2005","unstructured":"Chisholm D, van Ommeren M, Ayuso-Mateos JL, Saxena S. Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder. Br J Psychiatry. 2005, 187:559-67. 10.1192\/bjp.187.6.559","journal-title":"Br J Psychiatry"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.3111\/13696990903266612","article-title":"Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder","volume":"12","author":"Woodward TC","year":"2009","unstructured":"Woodward TC, Tafesse E, Quon P, Kim J, Lazarus A. Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder. J Med Econ. 2009, 12:259-68. 10.3111\/13696990903266612","journal-title":"J Med Econ"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta E","year":"2008","unstructured":"Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord. 2008, 109:251-63. 10.1016\/j.jad.2008.06.001","journal-title":"J Affect Disord"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.2165\/11538350-000000000-00000","article-title":"Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder","volume":"28","author":"Woodward TC","year":"2010","unstructured":"Woodward TC, Tafesse E, Quon P, Lazarus A. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder. Pharmacoeconomics. 2010, 28:751-64. 10.2165\/11538350-000000000-00000","journal-title":"Pharmacoeconomics"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.2165\/11208500-000000000-00000","article-title":"Quetiapine: a pharmacoeconomic review of its use in bipolar disorder","volume":"30","author":"Plosker GL","year":"2012","unstructured":"Plosker GL. Quetiapine: a pharmacoeconomic review of its use in bipolar disorder. Pharmacoeconomics. 2012, 30:611-31. 10.2165\/11208500-000000000-00000","journal-title":"Pharmacoeconomics"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.06.009","article-title":"Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis","volume":"31 Pt 1","author":"Fajutrao L","year":"2009","unstructured":"Fajutrao L, Paulsson B, Liu S, Locklear J. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis. Clin Ther. 2009, 31 Pt 1:1456-68. 10.1016\/j.clinthera.2009.06.009","journal-title":"Clin Ther"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.2165\/11594930-000000000-00000","article-title":"Cost effectiveness of quetiapine in patients with acute bipolar depression and in maintenance treatment after an acute depressive episode","volume":"30","author":"Ekman M","year":"2012","unstructured":"Ekman M, Lindgren P, Miltenburger C, Meier G, Locklear JC, Chatterton ML. Cost effectiveness of quetiapine in patients with acute bipolar depression and in maintenance treatment after an acute depressive episode. Pharmacoeconomics. 2012, 30:513-30. 10.2165\/11594930-000000000-00000","journal-title":"Pharmacoeconomics"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2006.12.4.322","article-title":"The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder","volume":"12","author":"Calvert NW","year":"2006","unstructured":"Calvert NW, Burch SP, Fu AZ, Reeves P, Thompson TR. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder. J Manag Care Pharm. 2006, 12:322-30. 10.18553\/jmcp.2006.12.4.322","journal-title":"J Manag Care Pharm"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden CL","year":"2003","unstructured":"Bowden CL, Calabrese JR, Sachs G, et al.. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003, 60:392-400. 10.1001\/archpsyc.60.4.392","journal-title":"Arch Gen Psychiatry"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S245166","article-title":"Pharmacological treatment of bipolar depression: what are the current and emerging options?","volume":"16","author":"Yalin N","year":"2020","unstructured":"Yalin N, Young AH. Pharmacological treatment of bipolar depression: what are the current and emerging options?. Neuropsychiatr Dis Treat. 2020, 16:1459-72. 10.2147\/NDT.S245166","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716002774","article-title":"The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis","volume":"47","author":"Kamenov K","year":"2017","unstructured":"Kamenov K, Twomey C, Cabello M, Prina AM, Ayuso-Mateos JL. The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis. Psychol Med. 2017, 47:414-25. 10.1017\/S0033291716002774","journal-title":"Psychol Med"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz018","article-title":"Improving functioning, quality of life, and well-being in patients with bipolar disorder","volume":"22","author":"Bonn\u00edn CD","year":"2019","unstructured":"Bonn\u00edn CD, Reinares M, Mart\u00ednez-Ar\u00e1n A, et al.. Improving functioning, quality of life, and well-being in patients with bipolar disorder. Int J Neuropsychopharmacol. 2019, 22:467-77. 10.1093\/ijnp\/pyz018","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08040488","article-title":"Adjunctive psychotherapy for bipolar disorder: state of the evidence","volume":"165","author":"Miklowitz DJ","year":"2008","unstructured":"Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry. 2008, 165:1408-19. 10.1176\/appi.ajp.2008.08040488","journal-title":"Am J Psychiatry"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001793","article-title":"Treatment-resistant bipolar disorder","volume":"11","author":"Gitlin M","year":"2006","unstructured":"Gitlin M. Treatment-resistant bipolar disorder. Mol Psychiatry. 2006, 11:227-40. 10.1038\/sj.mp.4001793","journal-title":"Mol Psychiatry"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.04.007","article-title":"Effects of adjunctive peer support on perceptions of illness control and understanding in an online psychoeducation program for bipolar disorder: a randomised controlled trial","volume":"142","author":"Proudfoot J","year":"2012","unstructured":"Proudfoot J, Parker G, Manicavasagar V, et al.. Effects of adjunctive peer support on perceptions of illness control and understanding in an online psychoeducation program for bipolar disorder: a randomised controlled trial. J Affect Disord. 2012, 142:98-105. 10.1016\/j.jad.2012.04.007","journal-title":"J Affect Disord"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20190004","article-title":"Evidence-based psychotherapies for bipolar disorder","volume":"17","author":"Novick DM","year":"2019","unstructured":"Novick DM, Swartz HA. Evidence-based psychotherapies for bipolar disorder. Focus (Am Psychiatr Publ). 2019, 17:238-48. 10.1176\/appi.focus.20190004","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.2993","article-title":"Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis","volume":"78","author":"Miklowitz DJ","year":"2021","unstructured":"Miklowitz DJ, Efthimiou O, Furukawa TA, Scott J, McLaren R, Geddes JR, Cipriani A. Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis. JAMA Psychiatry. 2021, 78:141-50. 10.1001\/jamapsychiatry.2020.2993","journal-title":"JAMA Psychiatry"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.29399\/npa.27419","article-title":"Cognitive behavioral therapy in treatment of bipolar disorder","volume":"58","author":"\u00d6zdel K","year":"2021","unstructured":"\u00d6zdel K, Kart A, T\u00fcrk\u00e7apar MH. Cognitive behavioral therapy in treatment of bipolar disorder. Noro Psikiyatr Ars. 2021, 58:S66-76. 10.29399\/npa.27419","journal-title":"Noro Psikiyatr Ars"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176849","article-title":"Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: a meta-analysis of randomized controlled trials","volume":"12","author":"Chiang KJ","year":"2017","unstructured":"Chiang KJ, Tsai JC, Liu D, Lin CH, Chiu HL, Chou KR. Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: a meta-analysis of randomized controlled trials. PLoS One. 2017, 12:e0176849. 10.1371\/journal.pone.0176849","journal-title":"PLoS One"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7177.149","article-title":"Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment","volume":"318","author":"Perry A","year":"1999","unstructured":"Perry A, Tarrier N, Morriss R, McCarthy E, Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ. 1999, 318:149-53. 10.1136\/bmj.318.7177.149","journal-title":"BMJ"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v11.i12.1407","article-title":"Psychoeducation in bipolar disorder: a systematic review","volume":"11","author":"Rabelo JL","year":"2021","unstructured":"Rabelo JL, Cruz BF, Ferreira JD, Viana BM, Barbosa IG. Psychoeducation in bipolar disorder: a systematic review. World J Psychiatry. 2021, 11:1407-24. 10.5498\/wjp.v11.i12.1407","journal-title":"World J Psychiatry"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00873","article-title":"The long-term effectiveness of psychoeducation for bipolar disorders in mental health services. A 4-year follow-up study","volume":"10","author":"Buizza C","year":"2019","unstructured":"Buizza C, Candini V, Ferrari C, et al.. The long-term effectiveness of psychoeducation for bipolar disorders in mental health services. A 4-year follow-up study. Front Psychiatry. 2019, 10:873. 10.3389\/fpsyt.2019.00873","journal-title":"Front Psychiatry"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1017\/S1352465812000628","article-title":"Psycho-education and group cognitive-behavioural therapy for clinical perfectionism: a case-series evaluation","volume":"41","author":"Steele AL","year":"2013","unstructured":"Steele AL, Waite S, Egan SJ, Finnigan J, Handley A, Wade TD. Psycho-education and group cognitive-behavioural therapy for clinical perfectionism: a case-series evaluation. Behav Cogn Psychother. 2013, 41:129-43. 10.1017\/S1352465812000628","journal-title":"Behav Cogn Psychother"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw057","article-title":"Psychoeducational and cognitive behavioral treatment programs: implementation and evaluation from 1995 to 2015 in Kraepelin's former hospital","volume":"42 Suppl 1","author":"Schaub A","year":"2016","unstructured":"Schaub A, Hippius H, M\u00f6ller HJ, Falkai P. Psychoeducational and cognitive behavioral treatment programs: implementation and evaluation from 1995 to 2015 in Kraepelin's former hospital. Schizophr Bull. 2016, 42 Suppl 1:S81-9. 10.1093\/schbul\/sbw057","journal-title":"Schizophr Bull"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00715.x","article-title":"Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions","volume":"2","author":"Miklowitz DJ","year":"200911","unstructured":"Miklowitz DJ, Scott J. Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions. Bipolar Disord. 200911, 2:110-22. 10.1111\/j.1399-5618.2009.00715.x","journal-title":"Bipolar Disord"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2018.00748","article-title":"Outpatient psychotherapy improves symptoms and reduces health care costs in regularly and prematurely terminated therapies","volume":"9","author":"Altmann U","year":"2018","unstructured":"Altmann U, Thielemann D, Zimmermann A, et al.. Outpatient psychotherapy improves symptoms and reduces health care costs in regularly and prematurely terminated therapies. Front Psychol. 2018, 9:748. 10.3389\/fpsyg.2018.00748","journal-title":"Front Psychol"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20661","article-title":"Targets and outcomes of psychotherapies for mental disorders: an\u00a0overview","volume":"18","author":"Cuijpers P","year":"2019","unstructured":"Cuijpers P. Targets and outcomes of psychotherapies for mental disorders: an\u00a0overview. World Psychiatry. 2019, 18:276-85. 10.1002\/wps.20661","journal-title":"World Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115441-therapeutic-application-of-lithium-in-bipolar-disorders-a-brief-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:38Z","timestamp":1707507518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115441-therapeutic-application-of-lithium-in-bipolar-disorders-a-brief-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":127,"URL":"https:\/\/doi.org\/10.7759\/cureus.29332","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,19]]}}}